Théa is an independent pharmaceutical company specialized in the research, development and commercialization of eye-care products.
Théa was set up twenty five years ago and has played an important role in the latest pharmacological advances. Today, it is the leading independent eye care group in Europe.
Based in Clermont-Ferrand, the laboratory has continued to expand by opening nearly 25 subsidiaries in Europe, Russia, North Africa and South America. Currently, the Théa group constitutes a network uniting more than 1400 members of staff worldwide, with its products available in more than 70 countries.
Théa is an independent family group, developed from a Research and Development start-up by Henri Chibret, a fourth generation member of an ophthalmic dynasty. Jean-Frédéric Chibret (a fifth generation family member) has presided over the company since 2008, with Henri Chibret remaining at the head of Théa Holding focused on developing the scientific and financial strategy of the group.